Abnormal myocardial glucose handling in patients with syndrome X: Effect of beta-adrenergic blockade

Giornale Italiano di Cardiologia

Volumn 27, Issue 11, 1997, Pages 1113-1120

  Fragasso, Gabriele ^a,b   Chierchia, Sergio L ^a   Rossetti, Enrico ^a   Landoni, Claudio ^a   Lucignani, Giovanni ^a   Fazio, Ferruccio ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Positron emission tomography (PET); Syndrome X

Indexed keywords

ATENOLOL; FLUORODEOXYGLUCOSE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; ANGINA PECTORIS; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL ARTICLE; FEMALE; GLUCOSE METABOLISM; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; SYNDROME X;

ADRENERGIC BETA-ANTAGONISTS; ATENOLOL; CORONARY CIRCULATION; EXERCISE TEST; FEMALE; GLUCOSE; HEART; HUMANS; MALE; MICROVASCULAR ANGINA; MIDDLE AGED; MYOCARDIUM;

EID: 0030701821     PISSN: 00465968     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. KEMP HG: Left ventricular function in patients with anginal syndrome and normal coronary arteriograms. Am J Cardiol 1973; 32: 375-376.
2. DWYER EM, WIENER L, Cox JW: Angina pectoris in patients with normal and abnormal coronary arteriograms: hemodynamic and clinical aspects. Am J Cardiol 1969; 23: 639-646.
3. ARBOGAST R, BOURASSA MG: Myocardial function during atrial pacing in patients with angina pectoris and normal coronary arteriograms: comparison with patients having significant coronary artery disease. Am J Cardiol 1973; 32: 257-263.
4. MAMMOHANSINGH P, PARKER JO: Angina pectoris with normal coronary arteriograms: hemodynamic and metabolic response to atrial pacing. Am Heart J 1975; 90: 555-561.
5. OPHERK D, ZEBE H, WEIHE E, ET AL: Reduced coronary dilatory capacity and ultrastructural changes of the myocardium in patients with angina pectoris but normal coronary arteriograms. Circulation 1981; 63: 817-825.
6. CANNON RO III, WATSON RM, ROSING DR, EPSTEIN SE: Angina caused by reduced vasodilator reserve of the small coronary arteries. J Am Coll Cardiol 1983; 1: 1359-1373.
7. GIBSON RJ, LEE KL, COBB F, JONES RH: Ejection fraction response to exercise in patients with chest pain and normal coronary arteriograms. Circulation 1981; 64: 952-957.
8. CANNON RO, BONOW RO, BACHARACH SL, ET AL: Left ventricular dysfunction in patients with angina pectoris, normal epicardial coronary arteries and abnormal vasodilator reserve. Circulation 1985; 71: 218-226.
9. SCHOFIELD PM, BROOKS NH, BENNET DH: Left ventricular dysfunction in patients with angina pectoris and normal coronary angiograms. Br Heart J 1986; 56: 327-333.
10. SCHOFIELD PM, BROOKS NH, COLGAN S, ET AL: Left ventricular function and oesophageal function in patients with angina pectoris and normal coronary angiograms. Br Heart J 1987; 58: 218-224.
11. FAVARO L, CAPLIN JL, FETTICHE JJ, DYMOND DS: Sex differences in exercise induced left ventricular dysfunction in patients with syndrome X. Br Heart J 1987; 57: 232-236.
12. NIHOYANNOPOULOS P, KASKI JC, CRAKE T, MASERI A: Absence of myocardial dysfunction during stress in patients with syndrome X. J Am Coll Cardiol 1991; 18: 1463-1470.
13. MELLER J, GOLDSMITH SJ, RUDIN A, ET AL: Spectrum of exercise thallium-201 myocardial perfusion imaging in patients with chest pain and normal coronary angiograms. Am J Cardiol 1979; 43: 717-723.
14. BERGER BC, ABRAMOVITZ R, PARK CH, ET AL: Abnormal thallium-201 scans in patients with chest pain and angiographically normal coronary arteries. Am J Cardiol 1983; 52: 365-370.
15. KAUL S, NEWELL JB, CHESLER DA, POHOST GM, OKADA RD, BOUCHER CA: Quantitative thallium imaging findings in patients with normal coronary angiographic findings and in clinically normal subjects. Am J Cardiol 1986; 57: 509-512.
16. TWEDDEL AC, MARTIN W, HUTTON I: Thallium scans in syndrome X. Br Heart J 1992; 68: 48-50.
17. ROMEO F, ROSANO GMC, MARTUSCELLI E, LOMBARDO L, VALENTE A: Long-term follow-up of patients initially diagnosed with syndrome X. Am J Cardiol 1993; 71: 669-673.
18. FRAGASSO G, ROSSETTI E, DOSIO F, ET AL: High prevalence of the thallium-201 reverse redistribution phenomenon in patients with syndrome X. Eur Heart J 1996; 17: 1482-1487.
19. CHIERCHIA S, MARGONATO A, FRAGASSO G, GEROSA S: Microvascular spasm can cause ischemia in patients with normal coronary arteries (abstract). Circulation 1990; 82: III-248.
20. FRAGASSO G, CHIERCHIA SL, PIZZETTI G, ET AL: Impaired left ventricular filling dynamics in patients with angina and angiographically normal coronary arteries: effect of β adrenergic blockade. Heart 1997; 77: 32-39.
21. ROMEO F, GASPARDONE A, CIAVOLELLA M, GIOFFRÈ P, REALE A: Verapamil versus acebutolol for syndrome X. Am J Cardiol 1988; 62: 312-313.
22. BUGIARDINI R, BORGHI A, BIAGETTI L, PUDDU P: Comparison of verapamil versus propranolol therapy in syndrome X. Am J Cardiol 1989; 63: 286-290.
23. GELTMAN EM, HENES G, SENNEFF MJ, SOBEL BE, BERGMANN SR: Increased myocardial perfusion at rest and diminished perfusion reserve in patients with angina and angiographically normal coronary arteries. J Am Coll Cardiol 1990; 16: 586-595.
24. CAMICI PG, GISTRI R, LORENZONI R, ET AL: Coronary reserve and exercise ECG in patients with chest pain and normal coronary angiograms. Circulation 1992; 86: 179-186.
25. CAMICI P, ARAUJO LI, SPINKS T, ET AL: Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium in patients with exercise-induced angina. Circulation 1986; 74: 81-88.
26. HEUSCH G, DEUSSEN A: The effects of cardiac sympathetic nerve stimulation on perfusion of stenotic coronary arteries in the dog. Circ Res 1983; 53: 8-15.
27. BROWN BG, LEE AB, BOLSON EL, DODGE HT: Reflex constriction of significant coronary stenoses as a mechanisms contributing to ischemic left ventricular dysfunction during isometric exercise. Circulation 1984; 70: 18-24.
28. CHIERCHIA S, MUIESAN L, DAVIES A, BALASUBRAMIAN V, GEROSA S, RAFTERY EB: Role of the sympathetic nervous system in the pathogenesis of chronic stable angina. Circulation 1990; 82: II71-II81.
29. CHIERCHIA S, GEROSA S, GLAZIER JJ: Beta-blockers for the treatment of angina pectoris: indications in relation to pathophysiological mechanisms. J Cardiovasc Pharmacol 1987; 10: S29-S33.
30. MUDGE GH JR, GROSSMAN W, MILLS RM JR, LESCH M, BRAUNWALD E: Reflex increase in coronary vascular resistance in patients with ischemic heart disease. N Engl J Med 1976; 295: 1133-1137.
31. ARMSTRONG PW, CHIONG MA, PARKER JO: Effects of propranolol on the hemodynamic, coronary sinus blood flow and myocardial metabolism response to atrial pacing. Am J Cardiol 1977; 40: 83-89.
32. JACKSON G, ATKINSON L, ORAM S: Improvement of myocardial metabolism in coronary arterial disease by beta-blockade. Br Heart J 1980; 29: 487-495.
33. THOMPSON DS, NAQVI N, JUUL SM, COLTART DJ, JENKINS BS, WEBBPEPLOE MM: Haemodynamic and metabolic effects of atenolol in patients with angina pectoris. Br Heart J 1980; 43: 668-679.
34. NIELSEN TT, BAGGER JP, THOMASSEN A: Improved myocardial lactate extraction after propranolol in coronary artery disease: effected by peripheral glutamate and free fatty acid metabolism. Br Heart J 1986; 55: 140-147.
35. DAY JL: The metabolic consequences of adrenergic blockade: a review. Metabolism 1975; 24: 987-996.
36. OPIE LD: Effects of regional ischemia on metabolism of glucose and fatty acids. Circ Res 1976; 38 (Suppl I): 375-387.
37. LECH JJ, JESMOK GJ, CALVERT DN: Effects of drugs and hormones on lipolysis in heart. Fed Proc 1977; 36: 2000-2008.
38. PISARENKO IO, SOLOMATINA ES, STUDNEVA IM, KANELKO VE: Protective effect of glutamic acid on cardiac function and metabolism during cardioplegia and reperfusion. Bas Res Cardiol 1983; 78: 534-543.
39. THOMASSEN A, NIELSEN TT, BAGGER JP, PEDERSEN AK, HENNINGSEN P: Antiischemic and metabolic effects of glutamate during pacing in patients with stable angina pectoris secondary to either coronary artery disease or Syndrome X. Am J Cardiol 1991; 68: 291-295.
40. MOTZ W, VOGT M, RABENAY O, SCHELER S, LUCKHOFF A, STRAVER BE: Evidence of endothelial dysfunction in coronary resistance vessels in patients with angina pectoris and normal coronary angiograms. Am J Cardiol 1991; 68: 996-1003.
41. VRINTS C, BULT H, HITTER E, HERMAN AG, SNOECK JP: Impaired endothelium dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms. J Am Coll Cardiol 1992; 19: 21-31.
42. QUYYUMI AA, CANNON RO III, PANZA JA, DIODATI JG, EPSTEIN SE: Endothelial dysfunction in patients with chest pain and normal coronary arteries. Circulation 1992; 86: 1864-1871.
43. EGASHIRA K, INOU T, HIROOKA Y, YAMADA A, URABE Y, TAKESHITA A: Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993; 328: 1659-1664.
44. MONTORSI P, FABBIOCCHI F, LOALDI A, ET AL: Coronary adrenergic hyperreactivity in patients with syndrome X and abnormal electrocardiogram at rest. Am J Cardiol 1991; 68: 1698-1703.
45. GROPLER RJ, SIEGEL BA, LEE KJ, ET AL: Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med 1990; 31: 1749-1756.
46. NGUYEN VAN TB, MOSSBERG KA, TEWSON TJ, ET AL: Temporal analysis of myocardial glucose metabolism by 2-18F-fluoro-2-deoxy-D-glucose. Am J Physiol 1990; 259: H1022-H1031.
47. FRAGASSO G, LUCIGNANI G, FAZIO F: Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans (Letter). J Nucl Med 1991; 32: 1831.
48. YAMADA K, ENDO S, FUKUDA H, ET AL: Experimental studies on myocardial glucose metabolism of rats with 18F-2-fluoro-2-deoxy-D-glucose. Eur J Nucl Med 1985; 10: 341-345.